Institute of Pharmaceutical Science, Franklin-Wilkins Building, King's College London , 150 Stamford Street, London SE1 9NH, U.K.
Biomacromolecules. 2015 Mar 9;16(3):733-42. doi: 10.1021/bm501649y. Epub 2015 Jan 30.
Conjugated polymer nanoparticles are being developed for a variety of diagnostic and theranostic applications. The conjugated polymer, F8BT, a polyfluorene derivative, was used as a model system to examine the biological behavior of conjugated polymer nanoparticle formulations stabilized with ionic (sodium dodecyl sulfate; F8BT-SDS; ∼207 nm; -31 mV) and nonionic (pegylated 12-hydroxystearate; F8BT-PEG; ∼175 nm; -5 mV) surfactants, and compared with polystyrene nanoparticles of a similar size (PS200; ∼217 nm; -40 mV). F8BT nanoparticles were as hydrophobic as PS200 (hydrophobic interaction chromatography index value: 0.96) and showed evidence of protein corona formation after incubation with serum-containing medium; however, unlike polystyrene, F8BT nanoparticles did not enrich specific proteins onto the nanoparticle surface. J774A.1 macrophage cells internalized approximately ∼20% and ∼60% of the F8BT-SDS and PS200 delivered dose (calculated by the ISDD model) in serum-supplemented and serum-free conditions, respectively, while cell association of F8BT-PEG was minimal (<5% of the delivered dose). F8BT-PEG, however, was more cytotoxic (IC50 4.5 μg cm(-2)) than F8BT-SDS or PS200. The study results highlight that F8BT surface chemistry influences the composition of the protein corona, while the properties of the conjugated polymer nanoparticle surfactant stabilizer used determine particle internalization and biocompatibility profile.
共轭聚合物纳米粒子正在被开发用于各种诊断和治疗应用。共轭聚合物 F8BT,一种聚芴衍生物,被用作模型体系来研究用离子(十二烷基硫酸钠;F8BT-SDS;207nm;-31mV)和非离子(聚乙二醇化 12-羟基硬脂酸;F8BT-PEG;175nm;-5mV)表面活性剂稳定的共轭聚合物纳米粒子制剂的生物行为,并与具有相似尺寸的聚苯乙烯纳米粒子(PS200;~217nm;-40mV)进行比较。F8BT 纳米粒子与 PS200 一样疏水(疏水相互作用色谱指数值:0.96),并在与含血清培养基孵育后显示出形成蛋白质冠的证据;然而,与聚苯乙烯不同的是,F8BT 纳米粒子不会在纳米粒子表面富集特定的蛋白质。J774A.1 巨噬细胞在含血清和无血清条件下分别内吞了约 20%和 60%的 F8BT-SDS 和 PS200 给药剂量(通过 ISDD 模型计算),而 F8BT-PEG 的细胞结合量最小(<5%的给药剂量)。然而,F8BT-PEG 的细胞毒性(IC50 为 4.5μgcm(-2)) 比 F8BT-SDS 或 PS200 高。研究结果表明,F8BT 的表面化学性质影响蛋白质冠的组成,而使用的共轭聚合物纳米粒子表面活性剂稳定剂的性质决定了颗粒的内化和生物相容性特征。